An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder

NCT00330655 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Binge Eating Disorder

Interventions

DRUG: memantine

Sponsor

Mclean Hospital

Collaborators

[object Object]